Fibrin clot strength measured by thrombelastography and outcomes after percutaneous coronary intervention

Thromb Haemost. 2017 Jan 26;117(2):426-428. doi: 10.1160/TH16-10-0496. Epub 2016 Nov 3.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Blood Coagulation*
  • Coronary Angiography
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / mortality
  • Coronary Artery Disease / therapy*
  • Coronary Thrombosis / blood
  • Coronary Thrombosis / etiology
  • Female
  • Fibrin / metabolism*
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Myocardial Infarction / blood
  • Myocardial Infarction / etiology
  • Percutaneous Coronary Intervention* / adverse effects
  • Percutaneous Coronary Intervention* / instrumentation
  • Percutaneous Coronary Intervention* / mortality
  • Platelet Aggregation Inhibitors / therapeutic use
  • Predictive Value of Tests
  • Proportional Hazards Models
  • Risk Factors
  • Stents
  • Tensile Strength
  • Thrombelastography*
  • Time Factors
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors
  • Fibrin